279 related articles for article (PubMed ID: 9017770)
101. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF
Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660
[TBL] [Abstract][Full Text] [Related]
102. Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril.
Barrios V; Escobar C; Echarri R
Vasc Health Risk Manag; 2008; 4(4):847-53. PubMed ID: 19066001
[TBL] [Abstract][Full Text] [Related]
103. Sustained antihypertensive activity of diltiazem SR: double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.
Whelton A; Eff J; Magner DJ
J Clin Pharmacol; 1992 Sep; 32(9):808-15. PubMed ID: 1430300
[TBL] [Abstract][Full Text] [Related]
104. Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension.
Shimamoto K; Kimoto M; Matsuda Y; Asano K; Kajikawa M
Hypertens Res; 2015 Oct; 38(10):695-700. PubMed ID: 25876832
[TBL] [Abstract][Full Text] [Related]
105. A series of N-of-1 trials to assess the therapeutic interchangeability of two enalapril formulations in the treatment of hypertension in Addis Ababa, Ethiopia: study protocol for a randomized controlled trial.
Alemayehu C; Mitchell G; Aseffa A; Clavarino A; McGree J; Nikles J
Trials; 2017 Oct; 18(1):470. PubMed ID: 29017595
[TBL] [Abstract][Full Text] [Related]
106. [Combination of slow-release diltiazem and a beta-blocker in arterial hypertension. 2 cases of cardiogenic shock with severe bradycardia].
Lamaison D; Vacher D; Berenfeld A; Schandrin C; Lavarenne V
Therapie; 1990; 45(5):411-3. PubMed ID: 1979694
[TBL] [Abstract][Full Text] [Related]
107. Long-term efficacy and safety of sustained-release diltiazem in the treatment of hypertension.
Myburgh DP
S Afr Med J; 1990 Oct; 78(8):456-7. PubMed ID: 2218780
[TBL] [Abstract][Full Text] [Related]
108. An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension.
Mallion JM
Blood Press Suppl; 2007 Oct; 2():13-8. PubMed ID: 18046974
[TBL] [Abstract][Full Text] [Related]
109. Heart rate-lowering and -regulating effects of once-daily sustained-release diltiazem.
Boden WE; Vray M; Eschwege E; Lauret D; Scheldewaert R
Clin Cardiol; 2001 Jan; 24(1):73-9. PubMed ID: 11195610
[TBL] [Abstract][Full Text] [Related]
110. Fixed-dose lercanidipine/enalapril for hypertension.
Menne J; Haller H
Drugs Today (Barc); 2008 Apr; 44(4):261-70. PubMed ID: 18536784
[TBL] [Abstract][Full Text] [Related]
111. Enalapril: a well-tolerated and efficacious agent for the paediatric hypertensive patient.
Miller K; Atkin B; Rodel PV; Walker JF
J Hypertens Suppl; 1986 Dec; 4(5):S413-6. PubMed ID: 3033181
[TBL] [Abstract][Full Text] [Related]
112. Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CD.
Massie BM; Chrysant SG; Jain A; Weir M; Weiss R; Korrin I
Clin Cardiol; 1997 Jun; 20(6):562-8. PubMed ID: 9181268
[TBL] [Abstract][Full Text] [Related]
113. Effects of nifedipine and enalapril on cardiac autonomic nervous function during the tilt test in elderly patients with hypertension.
Okabayashi J; Matsubayashi K; Doi Y; Sato T; Ozawa T
Hypertens Res; 1997 Mar; 20(1):1-6. PubMed ID: 9101305
[TBL] [Abstract][Full Text] [Related]
114. Comparison of isradipine and enalapril effects on regional carotid circulation in patients with hypertension with unilateral internal carotid artery stenosis.
Akopov SE; Simonian NA
J Cardiovasc Pharmacol; 1997 Nov; 30(5):562-70. PubMed ID: 9388037
[TBL] [Abstract][Full Text] [Related]
115. Clinical study on the hypotensive effect of diltiazem hydrochloride.
Maeda K; Takasugi T; Tsukano Y; Tanaka Y; Shiota K
Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):47-55. PubMed ID: 7216550
[TBL] [Abstract][Full Text] [Related]
116. Preventive effect of enalapril on erythrocytosis after renal transplantation.
Rhee SR; Park SK; Kang SK; Kim SH; Cho BH; Kim JH
Transplant Proc; 1996 Jun; 28(3):1555-6. PubMed ID: 8658783
[No Abstract] [Full Text] [Related]
117. A cooperative study to evaluate the efficacy and safety of enalapril in Puerto Rican patients with mild to moderate hypertension.
Medina-Ruiz A; Feliu JF
Drugs; 1990; 39 Suppl 2():77-82. PubMed ID: 2188827
[TBL] [Abstract][Full Text] [Related]
118. Systolic blood pressure response in three subgroups of hypertensives treated with sustained-release diltiazem.
Stallard MP; Park GD; Stewart WH; Waller ES; Covinsky JO
J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S117-9. PubMed ID: 2468893
[TBL] [Abstract][Full Text] [Related]
119. Trial logistics, implementation, and conduct of the OCTAVE mega study in Germany. Prospective, randomised, double-blind study to compare the efficacy and tolerability of omapatrilat and enalapril.
Kothny W; Kaaden R; Ludwig P; Chase D; Krekler M
Arzneimittelforschung; 2004; 54(8):474-9. PubMed ID: 15460215
[TBL] [Abstract][Full Text] [Related]
120. [Hypotensive effect and characteristics of the effect on the central hemodynamics of the delayed-action form of diltiazem (Dilren) in patients with hypertension].
Pshenitsin AI; Glotov MN; Mazur NA
Ter Arkh; 1993; 65(9):47-50. PubMed ID: 8303596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
